Page last updated: 2024-10-29

irsogladine and Adamantiades-Behcet Disease

irsogladine has been researched along with Adamantiades-Behcet Disease in 1 studies

irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt

Research Excerpts

ExcerptRelevanceReference
"Irsogladine 2-4 mg/day was administered orally to ten BD patients (cases 1-10), three men and seven women, with a mean age of 48."2.73Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study. ( Kamatani, N; Kotake, S; Nanke, Y; Ogiuchi, H; Okamoto, T, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nanke, Y1
Kamatani, N1
Okamoto, T1
Ogiuchi, H1
Kotake, S1

Trials

1 trial available for irsogladine and Adamantiades-Behcet Disease

ArticleYear
Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study.
    Drugs in R&D, 2008, Volume: 9, Issue:6

    Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Behcet Syndrome; Cell Communication; Female; Follow-

2008